These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 21607645)

  • 1. Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.
    Sodhi RK; Singh N; Jaggi AS
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):115-24. PubMed ID: 21607645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease.
    Kumar M; Sharma AA; Datusalia AK; Khatik GL
    Med Chem; 2024; 20(8):781-798. PubMed ID: 38726789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptors: emerging therapeutic targets for Alzheimer's disease.
    Sodhi RK; Singh N
    Pharmacol Res; 2013 Jun; 72():45-51. PubMed ID: 23542729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Synthetic Isoxazolone Derivative Role in Alzheimer's Disease: Computational and Pharmacological Approach.
    Ali M; Saleem U; Anwar F; Imran M; Nadeem H; Ahmad B; Ali T; Atta-Ur-Rehman ; Ismail T
    Neurochem Res; 2021 Apr; 46(4):905-920. PubMed ID: 33486698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.
    Singh AK; Singh SK; Nandi MK; Mishra G; Maurya A; Rai A; Rai GK; Awasthi R; Sharma B; Kulkarni GT
    Cent Nerv Syst Agents Med Chem; 2019; 19(3):154-170. PubMed ID: 31429696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update.
    Khan MA; Alam Q; Haque A; Ashafaq M; Khan MJ; Ashraf GM; Ahmad M
    Curr Neuropharmacol; 2019; 17(3):232-246. PubMed ID: 30152284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
    Woods LT; Ajit D; Camden JM; Erb L; Weisman GA
    Neuropharmacology; 2016 May; 104():169-79. PubMed ID: 26519903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer disease therapeutics.
    Irizarry MC; Hyman BT
    J Neuropathol Exp Neurol; 2001 Oct; 60(10):923-8. PubMed ID: 11589422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on oxidative stress and therapeutical implications in dementia.
    Durany N; Münch G; Michel T; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():68-73. PubMed ID: 10654103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?
    Doig AJ; Del Castillo-Frias MP; Berthoumieu O; Tarus B; Nasica-Labouze J; Sterpone F; Nguyen PH; Hooper NM; Faller P; Derreumaux P
    ACS Chem Neurosci; 2017 Jul; 8(7):1435-1437. PubMed ID: 28586203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic insight into the role of metformin in Alzheimer's disease.
    Sanati M; Aminyavari S; Afshari AR; Sahebkar A
    Life Sci; 2022 Feb; 291():120299. PubMed ID: 34999113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conquering Insulin Network Dysfunctions in Alzheimer's Disease: Where Are We Today?
    de la Monte SM
    J Alzheimers Dis; 2024; 101(s1):S317-S343. PubMed ID: 39422949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.